UB Paderborn / Katalog / Suche / in CDI

The Discovery of Novel Vasopressin V1b Receptor Ligands for Pharmacological, Functional and Structural Investigations

Journal of neuroendocrinology, 2004-04, Vol.16 (4), p.356-361

2004

Volltextzugriff (PDF)

PKD1 haploinsufficiency causes a syndrome of inappropriate antidiuresis in mice

Journal of the American Society of Nephrology, 2007-06, Vol.18 (6), p.1740-1753

2007

Volltextzugriff (PDF)

Key Amino Acids Located within the Transmembrane Domains 5 and 7 Account for the Pharmacological Specificity of the Human V1b Vasopressin Receptor

Molecular endocrinology (Baltimore, Md.), 2004-11, Vol.18 (11), p.2777-2789

2004

Volltextzugriff (PDF)

Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors

The Journal of clinical investigation, 1993-07, Vol.92 (1), p.224-231

1993

Volltextzugriff (PDF)

Immunomodulation and infection: identification of small molecule TLR3 blockers to combat deleterious inflammation in pneumonia

Critical care (London, England), 2014-12, Vol.18 (S2), p.P55-P55, Article P55

2014

Volltextzugriff (PDF)

Nonpeptide vasopressin receptor antagonists: development of selective and orally active V1a, V2 and V1b receptor ligands

Progress in brain research, 2002, Vol.139, p.197-210

2002

Volltextzugriff (PDF)

Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist

The Journal of clinical investigation, 1996-12, Vol.98 (12), p.2729-2738

1996

Volltextzugriff (PDF)

Growth inhibitory properties of endothelin-1 in activated human hepatic stellate cells: a cyclic adenosine monophosphate-mediated pathway. Inhibition of both extracellular signal-regulated kinase and c-Jun kinase and upregulation of endothelin B receptors

The Journal of clinical investigation, 1996-12, Vol.98 (12), p.2771-2778

1996

Volltextzugriff (PDF)

Nonpeptide antagonists for vasopressin receptors. Pharmacology of SR 121463A, a new potent and highly selective V2 receptor antagonist

Advances in experimental medicine and biology, 1998, Vol.449, p.427

Serradeil-Le Gal, C

1998

Volltextzugriff (PDF)

An Overview of SR121463, a Selective Non‐Peptide Vasopressin V2 Receptor Antagonist

Cardiovascular drug reviews, 2001-09, Vol.19 (3), p.201-214

Gal, C. Serradeil‐Le

2001

Volltextzugriff (PDF)

Benzophenanthridine alkaloids isolated from Eschscholtzia californica cell suspension cultures interact with vasopressin (V1) receptors

Planta medica, 1992-02, Vol.58 (1), p.35-38

1992

Volltextzugriff (PDF)

Single Amino Acid Substitutions and Deletions That Alter the G Protein Coupling Properties of the V2 Vasopressin Receptor Identified in Yeast by Receptor Random Mutagenesis

The Journal of biological chemistry, 2001-08, Vol.276 (31), p.29382-29392

2001

Volltextzugriff (PDF)

SSR126768A (4-chloro-3-[(3R)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2-oxo-2,3-dihydro-1H-indol-3-yl]-N-ethyl-N-(3-pyridylmethyl)-benzamide, hydrochloride): a new selective and orally active oxytocin receptor antagonist for the prevention of preterm labor

The Journal of pharmacology and experimental therapeutics, 2004-04, Vol.309 (1), p.414

2004

Volltextzugriff (PDF)

Vasopressin: A potent autocrine/paracrine regulator of mammal adrenal functions

Endocrine research, 1998-01, Vol.24 (3-4), p.703-710

1998

Volltextzugriff (PDF)

Effect of a new, potent, non-peptide V1a vasopressin antagonist, SR 49059, on the binding and the mitogenic activity of vasopressin on Swiss 3T3 cells

Biochemical pharmacology, 1994-02, Vol.47 (4), p.633-641

1994

Volltextzugriff (PDF)

Characterization of NPY receptors controlling lipolysis and leptin secretion in human adipocytes

FEBS letters, 2000-06, Vol.475 (2), p.150-156

2000

Volltextzugriff (PDF)

Differential Sensitivity to Cardiotonic Drugs of Cyclic AMP Phosphodiesterases Isolated from Canine Ventricular and Sinoatrial-Enriched Tissues

Journal of cardiovascular pharmacology, 1989-08, Vol.14 (2), p.213-220

1989

Volltextzugriff (PDF)

Binding properties of a selective tritiated vasopressin V2 receptor antagonist, [3H]-SR 121463

Kidney international, 2000-10, Vol.58 (4), p.1613-1622

2000

Volltextzugriff (PDF)

Comparative pharmacology of bovine, human and rat vasopressin receptor isoforms

European journal of pharmacology, 2004-10, Vol.501 (1), p.59-69

2004

Volltextzugriff (PDF)

Receptor for advanced glycation endproducts controls deleterious lung inflammation in severe Pseudomonas aeruginosa pneumonia in immunosuppressed mice

Critical care (London, England), 2012-01, Vol.16 (S3), p.P14-P14, Article P14

2012

Volltextzugriff (PDF)

Importance of the phenotypic state of vascular smooth muscle cells on the binding and the mitogenic activity of endothelin

Peptides (New York, N.Y. : 1980), 1991-05, Vol.12 (3), p.575-579

1991

Volltextzugriff (PDF)

Effect of SR-49059, a vasopressin V1a antagonist, on human vascular smooth muscle cells

American journal of physiology. Heart and circulatory physiology, 1995-01, Vol.268 (1), p.H404-H410

1995

Volltextzugriff (PDF)

Vasopressin receptors in human adrenal medulla and pheochromocytoma

The journal of clinical endocrinology and metabolism, 1999-06, Vol.84 (6), p.2195-2203

1999

Volltextzugriff (PDF)

Receptor binding of oxytocin and vasopressin antagonists and inhibitory effects on isolated myometrium from preterm and term pregnant women

BJOG : an international journal of obstetrics and gynaecology, 1999-10, Vol.106 (10), p.1047-1053

1999

Volltextzugriff (PDF)

Binding properties of three neuropeptide Y receptor subtypes from zebrafish: comparison with mammalian Y1 receptors

Biochemical pharmacology, 2000-12, Vol.60 (12), p.1815-1822

2000

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

The Discovery of Novel Vasopressin V1b Receptor Ligands for Pharmacological, Functional and Structural Investigations

PKD1 haploinsufficiency causes a syndrome of inappropriate antidiuresis in mice

Key Amino Acids Located within the Transmembrane Domains 5 and 7 Account for the Pharmacological Specificity of the Human V1b Vasopressin Receptor

Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors

Immunomodulation and infection: identification of small molecule TLR3 blockers to combat deleterious inflammation in pneumonia

Nonpeptide vasopressin receptor antagonists: development of selective and orally active V1a, V2 and V1b receptor ligands

Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist

Growth inhibitory properties of endothelin-1 in activated human hepatic stellate cells: a cyclic adenosine monophosphate-mediated pathway. Inhibition of both extracellular signal-regulated kinase and c-Jun kinase and upregulation of endothelin B receptors

Nonpeptide antagonists for vasopressin receptors. Pharmacology of SR 121463A, a new potent and highly selective V2 receptor antagonist

An Overview of SR121463, a Selective Non‐Peptide Vasopressin V2 Receptor Antagonist

Benzophenanthridine alkaloids isolated from Eschscholtzia californica cell suspension cultures interact with vasopressin (V1) receptors

Single Amino Acid Substitutions and Deletions That Alter the G Protein Coupling Properties of the V2 Vasopressin Receptor Identified in Yeast by Receptor Random Mutagenesis

SSR126768A (4-chloro-3-[(3R)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2-oxo-2,3-dihydro-1H-indol-3-yl]-N-ethyl-N-(3-pyridylmethyl)-benzamide, hydrochloride): a new selective and orally active oxytocin receptor antagonist for the prevention of preterm labor

Vasopressin: A potent autocrine/paracrine regulator of mammal adrenal functions

Effect of a new, potent, non-peptide V1a vasopressin antagonist, SR 49059, on the binding and the mitogenic activity of vasopressin on Swiss 3T3 cells

Characterization of NPY receptors controlling lipolysis and leptin secretion in human adipocytes

Differential Sensitivity to Cardiotonic Drugs of Cyclic AMP Phosphodiesterases Isolated from Canine Ventricular and Sinoatrial-Enriched Tissues

Binding properties of a selective tritiated vasopressin V2 receptor antagonist, [3H]-SR 121463

Comparative pharmacology of bovine, human and rat vasopressin receptor isoforms

Receptor for advanced glycation endproducts controls deleterious lung inflammation in severe Pseudomonas aeruginosa pneumonia in immunosuppressed mice

Importance of the phenotypic state of vascular smooth muscle cells on the binding and the mitogenic activity of endothelin

Effect of SR-49059, a vasopressin V1a antagonist, on human vascular smooth muscle cells

Vasopressin receptors in human adrenal medulla and pheochromocytoma

Receptor binding of oxytocin and vasopressin antagonists and inhibitory effects on isolated myometrium from preterm and term pregnant women

Binding properties of three neuropeptide Y receptor subtypes from zebrafish: comparison with mammalian Y1 receptors

Aktive Filter

Suchergebnisse filtern